CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −400 | $425.15 | $170K | 63,488 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,000 | $426.66 | $427K | 62,488 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,227 | $427.61 | $525K | 61,261 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,320 | $428.58 | $566K | 59,941 |
| 2020-08-11 | Dahut Karen M Director | Grant or award | +1,160 | $0.00 | $1 | 1,160 |
| 2020-08-10 | Selvaraj Shelly Ramasamy SVP Information Technology | Sale | −400 | $439.31 | $176K | 22,041 |
| 2020-08-10 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −500 | $439.31 | $220K | 28,176 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −513 | $431.77 | $221K | 44,467 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −400 | $433.57 | $173K | 44,067 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −7 | $434.00 | $3K | 44,060 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −571 | $435.70 | $249K | 43,489 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −125 | $437.24 | $55K | 43,364 |
| 2020-08-10 | ALTMAN STEVEN R Director | Sale | −384 | $439.31 | $169K | 42,980 |
| 2020-07-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −200 | $421.62 | $84K | 75,739 |
| 2020-07-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −100 | $424.50 | $42K | 75,639 |
| 2020-07-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −437 | $427.21 | $187K | 75,202 |
| 2020-07-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −211 | $428.10 | $90K | 74,991 |
| 2020-07-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −583 | $429.54 | $250K | 74,408 |
| 2020-07-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −200 | $421.62 | $84K | 4,391 |
| 2020-07-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −83 | $424.63 | $35K | 4,308 |
Page 50 of 55 · 1,082 trades